Oral Minoxidil Metabolism and Energy Expenditure: What the Evidence Actually Shows

At a glance

• Absorption / at least 90% absorbed [1]
• Peak plasma level / within the first hour [1]
• Average plasma half-life / 4.2 hours [1]
• Metabolism / about 90% metabolized, mainly by glucuronide conjugation; no named CYP enzyme in the label [1]
• Duration of blood pressure effect / about 75 hours after a dose [1]
• Heart rate with low-dose use / mean +2.67 beats/min in a meta-analysis [2]

Does oral minoxidil increase energy expenditure?

We found no published study that measured resting energy expenditure, total daily energy expenditure or thermogenesis in people taking oral minoxidil for hair loss. The oral label describes minoxidil as a direct-acting peripheral arteriolar vasodilator that lowers blood pressure by decreasing peripheral vascular resistance. [1] The fall in pressure triggers reflex increases in heart rate, cardiac output, renin and salt and water retention. [1] Those are hemodynamic effects, not measurements of calorie use.

A 2025 meta-analysis of low-dose oral minoxidil (5 mg/day or less) in alopecia found a mean heart rate increase of 2.67 beats/min (95% CI 0.34 to 5.01) and no significant change in systolic or diastolic blood pressure. [2]

How is oral minoxidil absorbed and metabolized?

The oral label states that minoxidil is at least 90% absorbed, that plasma levels peak within the first hour, and that the average plasma half-life is 4.2 hours. [1] About 90% is metabolized, mainly by glucuronide conjugation (N-oxide), not by a named CYP enzyme in the label. [1] Blood pressure starts to fall within 30 minutes, reaches its minimum at 2 to 3 hours, and the effect lasts about 75 hours; the label notes that the extent and time course of blood pressure reduction do not correspond closely to plasma concentration. [1]

What does the label say about heart rate and fluid retention?

At hypertension doses, the oral label carries a boxed warning for pericardial effusion, occasionally progressing to tamponade, and for worsened angina. [1] It says minoxidil should be reserved for patients who do not respond to a diuretic plus two other antihypertensives, and that it is usually given with a beta blocker to prevent tachycardia and a diuretic to prevent fluid accumulation. [1] The label also says minoxidil increases heart rate, that reversible edema occurred in about 10% of non-dialysis patients, and that a loop diuretic is almost always needed. [1]

At hair-loss doses, a retrospective multicenter study of 1404 patients found hypertrichosis in 15.1%, lightheadedness in 1.7%, fluid retention in 1.3% and tachycardia in 0.9%; systemic effects led to discontinuation in 1.2%, and no life-threatening adverse effects were observed. [3] Doses studied for hair loss, such as 1 mg/day and 5 mg/day, are off-label and below the label's effective antihypertensive range of 10 to 40 mg/day. [1][4][5]

What interactions matter for minoxidil metabolism?

The oral label names only one drug interaction: guanethidine, which can cause profound orthostatic hypotension; the label says guanethidine should be stopped before minoxidil is started if possible, otherwise minoxidil should be started in the hospital. [1] The label does not name CYP-mediated interactions. [1]

Frequently asked questions

›Does oral minoxidil speed up metabolism?

We found no study that measured energy expenditure or thermogenesis in people taking oral minoxidil. A change in heart rate does not establish whether calorie use changes.

›How is oral minoxidil metabolized?

The label says about 90% is metabolized, mainly by glucuronide conjugation (N-oxide), and it does not name a CYP enzyme [1].

›What is the half-life of oral minoxidil?

The average plasma half-life is 4.2 hours, while the blood pressure effect lasts about 75 hours [1].

›Does low-dose oral minoxidil raise heart rate?

The label describes reflex tachycardia [1]. A meta-analysis of 5 mg/day or less found a mean increase of 2.67 beats/min (95% CI 0.34 to 5.01) [2].

›Is oral minoxidil FDA-approved for hair loss?

No. Oral tablets are approved only for hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum doses of a diuretic plus two other antihypertensives; the label says use to promote hair growth is not an approved indication [1].

References

1. U.S. National Library of Medicine, DailyMed. Minoxidil tablets (oral), Par Health prescribing information. Minoxidil tablets (oral), Par Health label
2. Chen M, Weichert M, Guo W, Ruzic R, Briley J. Low-dose oral minoxidil does not significantly affect blood pressure: A systematic review and meta-analysis. J Am Acad Dermatol. 2025;92(3):554-555. Low-dose oral minoxidil does not significantly affect blood pressure: A systematic review and meta-analysis
3. Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, Moreno-Arrones ÓM, Saceda-Corralo D, Rodrigues-Barata R, et al. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
4. Penha MA, Miot HA, Kasprzak M, Müller Ramos P. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial. JAMA Dermatol. 2024;160(6):600-605. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial
5. Asilian A, Farmani A, Saber M. Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial. J Cosmet Dermatol. 2024;23(3):949-957. Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial